Exodus Point Capital Management, LP Fulgent Genetics, Inc. Transaction History

Exodus Point Capital Management, LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	BUY	$26.74 - $40.81 $3,609 - $5,509	135 Added 0.61%	22,104 $591,000
Q2 2023 Aug 10, 2023	SELL	$28.52 - $40.7 $1.76 Million - $2.52 Million	-61,858 Reduced 73.79%	21,969 $814,000
Q1 2023 May 11, 2023	BUY	$29.39 - $36.27 $2.46 Million - $3.04 Million	83,827 New	83,827 $2.62 Million
Q3 2022 Nov 10, 2022	SELL	$37.92 - $63.74 $394,443 - $663,023	-10,402 Reduced 43.88%	13,303 $507,000
Q2 2022 Aug 19, 2022	BUY	$47.98 - $62.75 $783,657 - $1.02 Million	16,333 Added 221.55%	23,705 $1.29 Million

Q1 2022 May 13, 2022	BUY	$49.85 - $96.11 $203,687 - $392,705	4,086 Added 124.35%	7,372 $460,000
Q4 2021 Feb 11, 2022	BUY	$77.3 - $105.0 $254,007 - $345,030	3,286 New	3,286 $331,000
Q2 2020 Aug 14, 2020	SELL	$8.89 - $18.28 $299,841 - $616,547	-33,728 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$6.75 - $19.75 $722 - $2,113	-107 Reduced 0.32%	33,728 $363,000
Q4 2019 Feb 14, 2020	BUY	$9.29 - $15.82 $314,327 - $535,269	33,835 New	33,835 $436,000

199

14.7M

1.16M

92.9K

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $594M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.